New and Generic Drug Approvals from FDA

Download PDF Copy

Apr 14 2004

Inactive Ingredient Database (updated)

New and Generic Drug Approvals
- Colgate Total Toothpaste, Colgate-Palmolive Company
- Heparin Sodium in 5% Dextrose Injection, B. Braun Medical Inc.
- Heparin Sodium in 0.9% Sodium Chloride Injection, B. Braun Medical Inc.
- Lovenox (enoxaparin sodium) Injection, Aventis Pharmaceuticals
- Terconazole Vaginal Cream, Taro Pharmaceuticals
- Tylenol Arthritis Pain (650 mg acetaminophen) extended release tablets, McNeil Consumer

Posted in: Pharmaceutical News

Tags: Acetaminophen, Arthritis, Dextrose, Generic Drug, Heparin, Pain, Pharmaceuticals

Comments (0)

Download PDF Copy

Suggested Reading

Combination therapy shows promising results in treating stage 3 melanoma

Combination therapy shows promising results in treating stage 3 melanoma

Breakthrough pig kidney transplant ends dialysis for Alabama woman

Breakthrough pig kidney transplant ends dialysis for Alabama woman

New study reveals complex attitudes toward psychedelic therapy

New study reveals complex attitudes toward psychedelic therapy

Obesity crisis in the U.S. expected to worsen by 2050

Obesity crisis in the U.S. expected to worsen by 2050

Danish studies find increased risk of optic nerve damage with diabetes medicine

Danish studies find increased risk of optic nerve damage with diabetes medicine

Breakthrough in HWE reaction offers pathway for anti-cancer drug development

Breakthrough in HWE reaction offers pathway for anti-cancer drug development

Aging reduces cancer risk by limiting cell regeneration

Aging reduces cancer risk by limiting cell regeneration

New modular strategy reduces piperidine synthesis steps for pharmaceuticals

New modular strategy reduces piperidine synthesis steps for pharmaceuticals

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Imlunestrant offers new hope for ER-positive HER2-negative breast cancer